215570 fundamentals
Key facts
Cronex Co., Ltd. engages in the provision of research and development services. It operates through the following business divisions: Xenograft, Minipig, and Contract Research Organization (CRO). The Xenograft business division refers to the development and transplant of animal tissues and organs into human bodies. The Minipig business division focuses on research of minipigs. The Contract Research Organization (CRO) business division is involved in research and development of products such as pharmaceuticals, food, cosmetics, chemicals, and agricultural chemicals. The company was founded on May 1, 2012 and is headquartered in Hwaseong-si, South Korea.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
Financial health
Financial position and solvency of the company